KRASLOQ Trademark

Trademark Overview


On Tuesday, October 6, 2020, a trademark application was filed for KRASLOQ with the United States Patent and Trademark Office. The USPTO has given the KRASLOQ trademark a serial number of 90238399. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2023. This trademark is owned by Mirati Therapeutics, Inc.. The KRASLOQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorect...

research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
krasloq

General Information


Serial Number90238399
Word MarkKRASLOQ
Filing DateTuesday, October 6, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and Servicespharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
Goods and Servicesresearch and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 20, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMirati Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameMirati Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, February 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU EXTENSION 1 GRANTED
Thursday, June 30, 2022SOU EXTENSION 1 FILED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 10, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 10, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 10, 2021NON-FINAL ACTION WRITTEN
Thursday, March 4, 2021ASSIGNED TO EXAMINER
Friday, November 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 9, 2020NEW APPLICATION ENTERED